Pharmacoloov. Universitv of california. Davis. California ~nesthef;;ed young abult Wistar rat; were given either human serum a1 bumin (HSA), 1.5 gmlkg, or saline, intravenously. Ten minutes later the blood brain barrier (BBB) in one hemisphere was opened by carotid artery infusion of hypertonic arabinose.
Pharmacoloov. Universitv of california. Davis. California ~nesthef;;ed young abult Wistar rat; were given either human serum a1 bumin (HSA), 1.5 gmlkg, or saline, intravenously. Ten minutes later the blood brain barrier (BBB) in one hemisphere was opened by carotid artery infusion of hypertonic arabinose.
Bilirubin was then infused intravenously over 8 minutes. Serial blood samples were obtained for total bilirubin (TB) and free bilirubin (FB) determinations (peroxidase method) until sacrifice 30 minutes later. Cortical EEGs were recorded continuously.
Osmotic opening of the BBB resulted in yellow coloration of the affected hemisphere in both control and HSA primed animals. EEG changes, ranging from a transient decrease in amplitude to permanent cessation of electrical activity, occurred at a mean TB of 54.8k12.6 mgldl in HSA primed rats (n=8) compared with a threshold of 30.4t6.4 mg/dl in control rats (n=ll) (p<.001). At comparable TB levels, FB levels were lower in HSA primed animals. Neither EEG changes nor staining developed in animals with an intact BBB.
These data suggest that yellow "staining" of brains may sometimes represent non-toxic interstitial bil i rubin-albumin since neurotoxicity, as measured by EEG changes, was related to the level of FB available for binding to tissue rather than the TB level. Given a critical level of FB variations in BBB permeability to bilirubin or a1 bumin-bil irubin may contribute to the risk for encephalopathy.
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To determine the incidence of hypoglycemia in the large infant of the nondiabetic mother, 789 consecutive newborns with birth weight more than 3900 grams were screened at 1,2 & 4 hrs. postnatal age with a heel stick J&xtrostixm. A serum glucose was obtained when the Dextrostix was less than 45mgfd1.17 infants (2.2%) had a serum glucose less than 35mgldl. One infant had group B streptococcal sepsis and another nesidioblastosis. No etiology for the hypoglycemia was evident in the remaining 15 infants. The average serum glucose of the 15 hypoglycemic infants was 2lmgIdl t 9 with 3 infants less than lomgldl. 515 infants tested were hyperinsulinemic while hypoglycemic. Only 1 infant wassymptomatic. None of the 15 mothers had diabetes mellitus when carefully screened at the first prenatal visit and at 28 weeks gestation.
Each of the 15 hypoglycemic newborns was paired with 2 normoglycemic infants of equivalent birth weight and born the same month, and the groups compared. There were no differences in gestational age, apgar score, temperature, maternal age, maternal height, medications, IV fluids, or route of delivery.
Maternal weight, however, at the first prenatal visit was significantly greater in the hypoglycemic group (88 kg t 18) when compared to the normoglycemic group (65 kg t 13)(P<.0001).
In summary, large infants born to obese mothers form a new group at risk for significant hypoglycemia. We investigated the potential role of maternal VLOL as a source of fatty acids (FA) for use by the fetus using isolated perfused human placenta. Recirculating fetal and maternal perfusions of 10 cm diameter portions of 5 term placentas were used to determine the fate of 3~-(~~)triol ein (TG) incorporated into human VLDL. Perfusates consisted of Kreb's bicarbonate buffer, 4% FA-free BSA, 100 mg% glucose, and 20% human RBC. The model was validated by oxygen uptake, glucose utilization, leucine transport, and BSP exclusion. VLDL was added to the maternal perfusates and circulations maintained for 2 hours. VLOL became TG depleted (62.5 + 1.6 (SE) % to 49.0 4.2) and phospholipid enriched (25.0 + c.9 to 37.2 + 7.8). Scintillation counting of perfusates revealed the following: the rate of uptake of VLDL-TG by placenta was 0.76 0.14 ug/g placentalmin which represents over the length of the perfusion, 11.7 2.3% of the initial TG A paucity of data is available on the cardiopulmonary resuscitation (CPR) of newborns. Since predictors of long term outcome following resuscitation would be extremely valuable we undertook a study to help define these variables. All admissions to the Neonatal ICU in a 30 month period (January 1981 -June 1983 were reviewed to identify episodes of CPR. Of the 1341 charts reviewed, 83 patients met the criteria for a "code" consisting of CPR with or without medications or procedures. Sixty seven patients (81%) survived the initial arrest however 37 patients (44%) succumbed within 24 hrs. Eighteen patients (22%) died prior to discharge and twelve patients (14%) were eventually dismissed. Prior to arrest, significant predictors of poor outcome were a urine output of <1 cc/kg/hr, sepsis and postnat.31 age < 24 hours (p<0.04). A pH < 7.30 twenty four hours after CPR or the occurance of intraventricular hemorrhage subsequent to the code were significantly associated with ultimate demise. A Chi square analysis indicated that the requirements of intravenous lines or intubation during a code was advantageous (p<0.04). Survivors of CPR were more likely to have BPD, to be term gestation and not to have subsequent arrests (p<O.O1). Six (55%) of the long term survivors (alive 6 months after discharge) were neurologically intact. Four (36%) were abnormal, but two of these infants had congenital anomalies associated with neurologic deficits. One patient was lost to follow-up. The clinical, socio-economic and ethical implications of this study warrant further analysis.
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